RxDoctor Payments Data

Edward Powers

Obstetrics & Gynecology · Dallas, TXNPI 1952755589

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (54.0%), food and beverage and education — rather than concentrated in one kind of arrangement. 27 manufacturers reported payments, led by Mimedx Group, Inc. at 54.0% of the total. 2025 is the largest year on record at $1,704, more than ten times the $150 reported in 2020.

$4,813in general payments, 2019–2025

Across 112 payments — averaging $42.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mimedx Group, Inc.$3K
  • AbbVie$727
  • Exeltis, USA Inc.$183
  • Organon$152
  • Astellas Pharma US Inc$141
  • Shield Therapeutics Inc$117
  • plus $893 from 21 others

What the payments were for

  • Consulting fees$2,60054%
  • Food & beverage$2,12344%
  • Education$902%

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,813 in reported general payments places this provider in the 80th percentile of 3,099 obstetrics & gynecology providers in Texas.

See all obstetrics & gynecology providers in Texas →

Other obstetrics & gynecology in Dallas

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →